Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
Systematic review |
827 people 5 RCTs in this analysis |
Blood problems
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 1.90 95% CI 0.97 to 3.71 |
Not significant | |
Systematic review |
827 people 5 RCTs in this analysis |
Drowsiness
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 1.22 95% CI 1.11 to 1.34 |
Small effect size | first-generation antipsychotic drugs |
Systematic review |
827 people 5 RCTs in this analysis |
Too much salivation
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 2.01 95% CI 1.74 to 2.32 |
Moderate effect size | first-generation antipsychotic drugs |
Systematic review |
383 people 3 RCTs in this analysis |
Too little salivation
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 0.27 95% CI 0.16 to 0.45 |
Moderate effect size | clozapine |
Systematic review |
484 people 3 RCTs in this analysis |
Weight gain
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 1.33 95% CI 1.11 to 1.59 |
Small effect size | first-generation antipsychotic drugs |
Systematic review |
521 people 4 RCTs in this analysis |
Movement disorder
with clozapine with haloperidol/chlorpromazine Absolute results not reported |
RR 0.77 95% CI 0.67 to 0.90 |
Small effect size | clozapine |